|
1
|
Adler LP, Blair HF, Makley JT, Williams
RP, Joyce MJ, Leisure G, al-Kaisi N and Miraldi F: Noninvasive
grading of musculoskeletal tumors using PET. J Nucl Med.
32:1508–1512. 1991.PubMed/NCBI
|
|
2
|
Feldman F, van Heertum R and Manos C:
18FDG PET scanning of benign and malignant musculoskeletal lesions.
Skeletal Radiol. 32:201–208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Watanabe H, Shinozaki T, Yanagawa T, Aoki
J, Tokunaga M, Inoue T, Endo K, Mohara S, Sano K and Takagishi K:
Glucose metabolic analysis of musculoskeletal tumours using
18fluorine-FDG PET as an aid to preoperative planning. J Bone Joint
Surg Br. 82:760–767. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pappo AS, Fontanesi J, Luo X, Rao BN,
Parham DM, Hurwitz C, Avery L and Pratt CB: Synovial sarcoma in
children and adolescents: the St Jude Children’s Research Hospital
experience. J Clin Oncol. 12:2360–2366. 1994.
|
|
5
|
Ueda T, Yoshikawa H, Mori S, Araki N,
Myoui A, Kuratsu S and Uchida A: Influence of local recurrence on
the prognosis of soft-tissue sarcomas. J Bone Joint Surg Br.
79:553–557. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tateishi U, Hosono A, Makimoto A, Sakurada
A, Terauchi T, Arai Y, Imai Y and Kim EE: Accuracy of 18F
fluorodeoxyglucose positron emission tomography/computed tomography
in staging of pediatric sarcomas. J Pediatr Hematol Oncol.
29:608–612. 2007. View Article : Google Scholar
|
|
7
|
Arush MW, Israel O, Postovsky S, Militianu
D, Meller I, Zaidman I, Sapir AE and Bar-Shalom R: Positron
emission tomography/computed tomography with 18fluoro-deoxyglucose
in the detection of local recurrence and distant metastases of
pediatric sarcoma. Pediatr Blood Cancer. 49:901–905. 2007.
View Article : Google Scholar
|
|
8
|
Yanagawa T, Shinozaki T, Iizuka Y,
Takagishi K and Watanabe H: Role of 2-deoxy-2-[F-18]
fluoro-D-glucose positron emission tomography in the management of
bone and soft-tissue metastases. J Bone Joint Surg Br. 92:419–423.
2010.
|
|
9
|
Hudson HM and Larkin RS: Accelerated image
reconstruction using ordered subsets of projection data. IEEE Trans
Med Imaging. 13:601–609. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flecher CDM, Unni KK and Mertens F:
Pathology and genetics; tumors of soft tissue and bone. 4. World
Health Organisation; Lyon: 2002
|
|
11
|
Kern KA, Brunetti A, Norton JA, Chang AE,
Malawer M, Lack E, Finn RD, Rosenberg SA and Larson SM: Metabolic
imaging of human extremity musculoskeletal tumors by PET. J Nucl
Med. 29:181–186. 1988.PubMed/NCBI
|
|
12
|
Benz MR, Dry SM, Eilber FC, Allen-Auerbach
MS, Tap WD, Elashoff D, Phelps ME and Czernin J: Correlation
between glycolytic phenotype and tumor grade in soft-tissue
sarcomas by 18F-FDG PET. J Nucl Med. 51:1174–1181. 2010. View Article : Google Scholar
|
|
13
|
Folpe AL, Lyles RH, Sprouse JT, Conrad EU
III and Eary JF: (F-18) fluorodeoxyglucose positron emission
tomography as a predictor of pathologic grade and other prognostic
variables in bone and soft tissue sarcoma. Clin Cancer Res.
6:1279–1287. 2000.
|
|
14
|
Völker T, Denecke T, Steffen I, Misch D,
Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H,
Henze G and Amthauer H: Positron emission tomography for staging of
pediatric sarcoma patients: results of a prospective multicenter
trial. J Clin Oncol. 25:5435–5441. 2007.PubMed/NCBI
|
|
15
|
Eftekhari F: Imaging assessment of
osteosarcoma in childhood and adolescence: diagnosis, staging, and
evaluating response to chemotherapy. Cancer Treat Res. 152:33–62.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheon GJ, Kim MS, Lee JA, Lee SY, Cho WH,
Song WS, Koh JS, Yoo JY, Oh DH, Shin DS and Jeon DG: Prediction
model of chemotherapy response in osteosarcoma by 18F-FDG PET and
MRI. J Nucl Med. 50:1435–1440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Griffeth LK, Dehdashti F, McGuire AH,
McGuire DJ, Perry DJ, Moerlein SM and Siegel BA: PET evaluation of
soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.
Radiology. 182:185–194. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda
T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K and Hatazawa J:
18F-FDG-PET of musculoskeletal tumors: a correlation with the
expression of glucose transporter 1 and hexokinase II. Ann Nucl
Med. 22:699–705. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aoki J, Watanabe H, Shinozaki T, Takagishi
K, Tokunaga M, Koyama Y, Sato N and Endo K: FDG-PET for
preoperative differential diagnosis between benign and malignant
soft tissue masses. Skeletal Radiol. 32:133–138. 2003. View Article : Google Scholar
|
|
20
|
Charest M, Hickeson M, Lisbona R,
Novales-Diaz JA, Derbekyan V and Turcotte RE: FDG PET/CT imaging in
primary osseous and soft tissue sarcomas: a retrospective review of
212 cases. Eur J Nucl Med Mol Imaging. 36:1944–1951. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bischoff M, Bischoff G, Buck A, von Baer
A, Pauls S, Scheffold F, Schultheiss M, Gebhard F and Reske SN:
Integrated FDG-PET-CT: its role in the assessment of bone and soft
tissue tumors. Arch Orthop Trauma Surg. 130:819–827. 2010.
View Article : Google Scholar
|
|
22
|
Bakheet SM, Saleem M, Powe J, Al-Amro A,
Larsson SG and Mahassin Z: F-18 fluorodeoxyglucose chest uptake in
lung inflammation and infection. Clin Nucl Med. 25:273–278. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bajpai J, Kumar R, Sreenivas V, Sharma MC,
Khan SA, Rastogi S, Malhotra A, Gamnagatti S, Kumar R, Safaya R and
Bakhshi S: Prediction of chemotherapy response by PET-CT in
osteosarcoma: correlation with histologic necrosis. J Pediatr
Hematol Oncol. 33:e271–e278. 2011.PubMed/NCBI
|
|
24
|
Gupta K, Pawaskar A, Basu S, Rajan MG,
Asopa RV, Arora B, Nair N and Banavali S: Potential role of FDG PET
imaging in predicting metastatic potential and assessment of
therapeutic response to neoadjuvant chemotherapy in Ewing sarcoma
family of tumors. Clin Nucl Med. 36:973–977. 2011. View Article : Google Scholar
|
|
25
|
Baum SH, Frühwald M, Rahbar K, Wessling J,
Schober O and Weckesser M: Contribution of PET/CT to prediction of
outcome in children and young adults with rhabdomyosarcoma. J Nucl
Med. 52:1535–1540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tateishi U, Kawai A, Chuman H, Nakatani F,
Beppu Y, Seki K, Miyake M, Terauchi T, Moriyama N and Kim EE:
PET/CT allows stratification of responders to neoadjuvant
chemotherapy for high-grade sarcoma: a prospective study. Clin Nucl
Med. 36:526–532. 2011. View Article : Google Scholar
|
|
27
|
Fortes DL, Allen MS, Lowe VJ, Shen KR,
Wigle DA, Cassivi SD, Nichols FC and Deschamps C: The sensitivity
of 18F-fluorodeoxyglucose positron emission tomography in the
evaluation of metastatic pulmonary nodules. Eur J Cardiothorac
Surg. 34:1223–1227. 2008. View Article : Google Scholar
|
|
28
|
Gould MK, Maclean CC, Kuschner WG, Rydzak
CE and Owens DK: Accuracy of positron emission tomography for
diagnosis of pulmonary nodules and mass lesions: a meta-analysis.
JAMA. 285:914–924. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bamba Y, Itabashi M and Kameoka S: Value
of PET/CT imaging for diagnosing pulmonary metastasis of colorectal
cancer. Hepatogastroenterology. 58:1972–1974. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schwab JH and Healey JH: FDG-PET lacks
sufficient sensitivity to detect myxoid liposarcoma spinal
metastases detected by MRI. Sarcoma. 2007:367852007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iagaru A, Chawla S, Menendez L and Conti
PS: 18F-FDG PET and PET/CT for detection of pulmonary metastases
from musculoskeletal sarcomas. Nucl Med Commun. 27:795–802. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kleis M, Daldrup-Link H, Matthay K,
Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA and
Franc BL: Diagnostic value of PET/CT for the staging and restaging
of pediatric tumors. Eur J Nucl Med Mol Imaging. 36:23–36. 2009.
View Article : Google Scholar
|
